Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology, Finnish heritage rare diseases and respiratory diseases for which Orion develops inhaled Easyhaler® pulmonary drugs.  

Pharmaceutical

Orion

Timo Lappalainen

Evgeny Berezin

Liisa Hurme

Satu Ahomäki

Olli Huotari

Virve Laitinen

Jari Karlson

The executive team at Orion Corporation has experience in a variety of industries, including controller at Genencor International and Cultor Oyj, and president and CEO at Orion Corporation. They also have a range of educational backgrounds, from business administration at the Turku School of Economics to industrian engineering at Helsinki University of Technology.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at Orion

Board of Directors

Leadership Team